U3 Pharma
Planegg, Bayern, Germany
About U3 Pharma
U3 Pharma GmbH, based in Martinsried near Munich, Germany, is a leader in targeted cancer drug development. Established in July 2001, the company has produced a pipeline of novel targeted therapeutics based on the ground-breaking discoveries made by its founder - Professor Axel Ullrich. Since May 2008 U3 Pharma belongs to DAIICHI Sankyo Co. Ltd., one of the top 20 leading pharmaceutical companies worldwide and no. 3 in Japan. Being part of this global environment, U3 Pharma is striving to provide patients around the world with innovative antibody-based therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $50.8M
- Funding stage: M&A
- Last round: Series Unknown (May 2006)
- Website: u3pharma.com
Industries & Categories
Biotechnology, Health Care
Canonical: https://fsome.com/organization/u3-pharma-2581041 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.